Leo Pharma A/S

https://www.leo-pharma.com

LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit. Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions. LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 93 million patients in 130 countries. In 2020, the company generated net sales of DKK 10,133 million. For more information, please visit www.LEO-Pharma.com *

	Start	1908-01-01 established
	End	1994-07-01 existent
	Group	Leo Pharma (Group)
	Industry	pharmaceutical
	Industry 2	dermatic
	Person	Aabo, Gitte (Leo Pharma 201511 CEO)
	Person 2	Kronborg, Anders (Leo Pharma 201510– EVP Global Finance, IT + Legal before Kinnevik Investment AB)

	Region	Ballerup
	Country	Denmark
	Street	55 Industriparken
	City	2750 Ballerup
	Tel	+45-44-945888
		Address record changed: 2020-12-02

Basic data	Employees	G: 5,001 to 10,000 (2021-12-03)
	Currency	DKK
	Annual sales	10,133,000,000 (sales, net, consolidated (2020) 2020-12-31)

		* Document for »About Section«: Aqilion AB. (12/3/21). "Press Release: Aqilion Strengthens the Company’s Pipeline through the Acquisition of a Phase-1 Ready Anti-inflammatory Program from LEO Pharma".

		Record changed: 2024-02-12